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Immune parameters change with time of day and disruption of circadian rhythms has been linked to inflam-
matory pathologies. A circadian-clock-controlled immune systemmight allow an organism to anticipate daily
changes in activity and feeding and the associated risk of infection or tissue damage to the host. Responses
to bacteria have been shown to vary depending on time of infection, with mice being more at risk of sepsis
when challenged ahead of their activity phase. Studies highlight the extent towhich themolecular clock,most
notably the core clock proteins BMAL1, CLOCK, and REV-ERBa, control fundamental aspects of the immune
response. Examples include the BMAL1:CLOCK heterodimer regulating toll-like receptor 9 (TLR9) expression
and repressing expression of the inflammatory monocyte chemokine ligand (CCL2) as well as REV-ERBa
suppressing the induction of interleukin-6. Understanding the daily rhythm of the immune system could
have implications for vaccinations and how we manage infectious and inflammatory diseases.Introduction
Organisms require the ability to tell the time of day in order to
anticipate and respond to changes in the external environment
imposed by solar time. This need is illustrated in the physiolog-
ical changes required to accommodate the daily pattern of
rest, activity, and feeding. Circadian rhythms are these daily
changes or oscillations in physiology and are due to numerous
genes whose expression peaks and troughs approximately
12 hr apart to undergo a full cycle within 24 hr. The full breadth
of control by the molecular clock on the genome was revealed
by R. Zhang et al. (2013, Keystone Symposia on Molecular
Clockworks, conference) who harvested multiple tissues at
2 hr intervals and found that more than a third of the mammalian
genome is under clock control.
The master clock resides in the suprachiasmatic nucleus
(SCN) of the brain and is oriented to the external environment
via the retinohypothalamic tract receiving light information from
the eye. The clock is cell autonomous and in its simplest form
consists as a transcription-translation oscillator loop. At the
core of this oscillator lies the heterodimeric partnership of the
basic-helix-loop-helix PER-ARNT-SIM (PAS) domain proteins,
BMAL1 (also known as ARNTL) and CLOCK, that bind E-box
sites and induce the expression of the repressors Period (PER)
and Cryptochrome (CRY), which in time translocate back into
the nucleus and inhibit their own expression by interfering with
the BMAL:CLOCK complex (Figure 1). As PER and CRY proteins
are gradually degraded, the repression on BMAL1 and CLOCK is
relieved and the cycle begins afresh with another 24 hr cycle.
This machinery lies at the heart of the circadian clock in the
SCN. However, an important finding was the existence of the
same clockwork machinery in peripheral cells (Schibler and Sas-
sone-Corsi, 2002) including fibroblasts cultured in vitro by what
is now known as the serum shock model (Balsalobre et al.,
1998). The serum shock model synchronizes cells so that circa-
dian gene expression and outputs of the clock can be analyzed
within an in vitro system. Since then, the molecular clock has
been characterized in immune cells (Boivin et al., 2003) including178 Immunity 40, February 20, 2014 ª2014 Elsevier Inc.macrophages (Keller et al., 2009), T cells (Bollinger et al., 2011),
dendritic cells, and B cells (Silver et al., 2012a).
Here we discuss recent findings indicating that certain clock
proteins, notably BMAL1, CLOCK, and REV-ERBa, can indeed
impact immune cell function, host defense, and inflammation.
The emerging picture is that time of day is critical to the nature
of the immune response and that dysregulation may lead to
inflammatory diseases or immunodeficiency. New therapeutic
options are presenting themselves that might provide a new
prospect for correcting pathologies associated with aberrant
immunity and inflammation.
The Anatomy of the Molecular Clock
Molecularly, the core oscillator is comprised of at least three in-
terlocking feedback loops. As stated above, the central loop
consists of the BMAL1:CLOCK heterodimer driving expression
of the repressors PER1-3 and CRY1-2, which feedback and limit
their own expression (Figure 1). This loop provides oscillations in
Per and Cry transcription and also oscillations in the activity of
the BMAL:CLOCK heterodimer.
The second loop consists of the nuclear receptors RAR-
related orphan receptor (ROR) (a,b,g) and REV-ERB (a,b) (also
known as NR1D1 and NR1D2), which through E-box activation
by BMAL1:CLOCK can then translocate back into the nucleus
to bind to receptor-related orphan receptor response elements
(ROREs) in the promoter of Bmal1 (Figure 1). RORs activate
whereas REV-ERBs repress the expression of BMAL1 (Preitner
et al., 2002; Sato et al., 2004). The third loop is comprised of
the transcriptional activator albumin D-box binding protein
(DBP), regulated through its E-box (loop 1) and the repressor nu-
clear factor interleukin 3 (NFIL3; also known as E4BP4), regu-
lated via a RORE (loop 2). These two factors then synergistically
regulate the expression of D-box genes including that of Per.
This tripartite system forms the foundation of themolecular oscil-
lator and controls the circadian network of clock-controlled
genes. In addition to this network of transcriptional control, post-
translational modifications provide a further layer of regulation
Figure 1. The Molecular Clock Consists of
at Least Three Interlocking Feedback Loops
Loop 1 consists of the core clock proteins BMAL1
and CLOCK binding to E-box elements within the
genes encoding the repressor proteins PER, CRY,
REV-ERBa RORa and DBP. After a period of time,
PERandCRYcan translocateback into thenucleus
and repress their ownexpressionby interferingwith
the BMAL1:CLOCK complex on the gene pro-
moter. The expression of these proteins is regu-
lated further by posttranslational modifications
such as phosphorylation of PER by CKIε, which
marks it for proteosomal degradation. Loop 2
consists of the alternate regulation by REV-ERBa
and RORa on RORE promoter elements, which in-
cludes Bmal1 and Nfil3. Loop 3 consists of the
alternate regulation by NFIL3 and DBP on D box
promoter elements. The clock products from each
of these loops can shuttle back to the nucleus and
either repress or reactivate these loops. The tran-
scription factorswithin eachof these loopscanalso
regulate clock-controlled genes (CCGs). These are
genes that have a circadian profile of expression
but do not feedback to affect the core molecular
clock. If some of these CCGs are themselves
transcription factors, they may confer a circadian
profile of expression on their target genes. There-
fore, the core clock components and CCGs have
the capacity to regulate transcription of a wide va-
rietyof cellularprograms that is independent of their
function within the molecular clock.
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lating the precision and function of the clock along with histone
modifications and the epigenetic code. These areas have been
reviewed extensively elsewhere (Aguilar-Arnal and Sassone-
Corsi, 2013; Bellet and Sassone-Corsi, 2010; Feng and Lazar,
2012).
Although not entirely understood, the SCN clock keeps periph-
eral clocks in harmony via the hypothalamus pituitary adrenal
(HPA) axis and the autonomic nervous system (ANS) and their
respective hormones glucocorticoids and the catecholamines
(epinephrine and norepinephrine), which act as synchronizing
messengers or ‘‘zeitgebers’’ to the peripheral clock (Curtis et al.,
2007; Kalsbeek et al., 2012). Circulating glucocorticoids, cate-
cholamines, and other hormones such as prolactin, melatonin,
and growth hormone, all of which affect the immune system,
peak at certain times of the day. The control by the SCN on these
autonomic and endocrine outputs keeps peripheral clocks,
including that of immunecells, inphasewitheachother andallows
for the coordination of a temporal program of physiology across
many tissues at certain times of the day (Guo et al., 2006).
The Molecular Clock Controls Antibacterial Host
Defense, Sepsis, and Inflammation
Pioneering studies in the 1960s and 1970s showed a striking
circadian variation in survival when mice were treated with lethal
doses of bacteria or bacterial products (Halberg et al., 1960;
Shackelford and Feigin, 1973). These studies showed enhanced
lethality toward the end of the resting phase, approximately 2 hr
before onset of activity. Mice are nocturnal species and therefore
the onset of activity occurs when lights are turned off in a mouse
facility. This is denoted by zeitgeber time (ZT), relating to the time
at which the lights are turned on and off in the animal facility. ZT0
denotes lights on and start of inactive phase and ZT12 denotes
lights off and start of activity phase (Figure 2). Numbers of leuko-cytes in the mouse circulation have a strong circadian variability
and reach their highest number at ZT5 and are recruited in
greater numbers into tissues at ZT13, just after the animal’s tran-
sition to activity (Scheiermann et al., 2012). These changes coin-
cide with the sensitivity to lipopolysaccharide (LPS) in which the
observed phenotype of increased cytokine release at ZT12
(Gibbs et al., 2012) could be in part due to rising leukocyte
numbers at this transition point. Host defense response is also
altered according to circadian time. Bellet et al. (2013) reported
that, after intragastric infection of wild-type mice with the path-
ogen Salmonella enterica Typhimurium at different circadian
times, ZT4 (day) and ZT16 (night), the degree of intestinal inflam-
mation and cytokine gene expression, as well as bacterial colo-
nization, change depending on both time of infection and time of
sacrifice (Bellet et al., 2013). The ability to clear the bacteria 72 hr
postinfection (hpi) from the colon was greater in mice infected
during the night (ZT16) than during the day (ZT4), but Clock
mutant mice had lower numbers of bacteria at both time points.
The authors found that the growth of Salmonella and its ability
to compete with other microorganisms in the gut is dependent
on the circadian regulation of antimicrobial peptides. They found
that the antimicrobial peptide lipocalin-2, to which Salmonella is
resistant, is higher during the day than at night. This suppresses
the resident microbiota, allowing for the higher outgrowth of
Salmonella during the day versus the night.
In addition, a circadian variation has been found in the ability of
mouse macrophages to ingest particles with the increase
observed ahead of the transition to activity (Hayashi et al.,
2007). This may also enhance bacterial clearance at the
beginning of the active phase. The induction of proinflammatory
cytokines and chemokine ligands is far greater when mice are
challenged with LPS at ZT12 versus ZT0. This includes a greater
induction of interleukin-6 (IL6), IL-12(p40), chemokine (C-Cmotif)
ligand 2 (CCL2), and CCL5 from macrophages challenged atImmunity 40, February 20, 2014 ª2014 Elsevier Inc. 179
Figure 2. Circadian Effects on Immune
Function
The data so far indicate a partitioning of the immune
system into two states: (1) a state of anticipation and
enhanced immune activity (red dotted line) and (2)
an opposing period that may relate to repair and
regeneration of the immune system (green dotted
line). Data indicate that around the time when mice
transition into activity (ZT12), the immune system is
poised and anticipates the higher risk of infection,
but with that comes enhanced susceptibility to
sepsis. This is evidenced by enhanced clearance of
bacteriaatZT8andZT10. Thisperiodalsocorrelates
with enhanced lethality from high doses of LPS
observed at ZT10, greater induction of proin-
flammatory cytokines at ZT12, and enhanced
numbers of leukocytes at ZT13. The opposing state
of regeneration and repair is mainly speculative and
requires further investigation. It does coincide,
however, with the period of reduced induction
of proinflammatory cytokines along with reduced
clearance and lethality from bacteria. Whether
similar processes occur in humans at the same
statesof transitionhaveyet tobeclearlydetermined.
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go some way to explaining the boost in host defense as mice
transition into activity, but equally the greater risk of sepsis re-
sulting from an overactive response. Keller et al. (2009) har-
vested peritoneal macrophages from mice every 4 hr for 24 hr
and performed microarray analysis. They found that 8% of the
macrophage transcriptome was cycling with a circadian varia-
tion, and when they analyzed genes involved in the toll-like re-
ceptor 4 (TLR4) pathway, they found circadian control on genes
involved in all aspects of the TLR4 response. This indicates
further that the entire TLR4 pathway in macrophages is under
tight circadian control and suggests again that the circadian
clock prepares the immune cell for an integrated response at
times of greatest risk.
Therefore, the temporal increase in chemoattractants, leuko-
cyte trafficking, proinflammatory cytokines, and phagocytic abil-
ity in the hours approaching the commencement of activity
is interpreted as being indicative of clock-controlled enhanced
sensitivity and immunosurveillance ahead of activity and feeding
when the risk of infection would be highest. Conversely, pertur-
bations or desynchronization of the clock (by modulating light
input) can adversely affect immune function. Under constant
dark conditions (Marpega´n et al., 2009) or with circadian de-
synchronization by experimental jet lag (Castanon-Cervantes
et al., 2010), a challenge of LPS in mice leads to an uncoordi-
nated and more severe inflammatory response and increased
mortality. One molecular feature of circadian desynchronization
by jet lag is a sustained reduction in Bmal1 transcript (Castanon-
Cervantes et al., 2010). This mirrors a ZT12 macrophage, in
which the circadian phase of Bmal1mRNA is at its lowest (Keller
et al., 2009). Macrophages subjected to jet lag and ZT12 macro-
phages have a heightened inflammatory response once acti-
vated by LPS, because both have low expression of BMAL1 prior
to activation. This suggests that BMAL1 (discussed in more
detail later) may be one of the central gatekeepers governing
the circadian inflammatory response (Figure 3).
The effects of the central clock in theSCNand its rhythmic con-
trol on autonomic and endocrine regulators are important deter-
minants of immune modulation (Logan and Sarkar, 2012). The180 Immunity 40, February 20, 2014 ª2014 Elsevier Inc.SCN produces diffusible signals as well as axonal projections
to both the paraventricular nucleus (PVN) and arcuate nucleus
(ARC) in the hypothalamus of the brain. For example, the PVN
governs noradrenergic input to the spleen and releases norepi-
nephrine tomodulate the activity of natural killer (NK) cells (Logan
et al., 2011). Also, the enhanced recruitment of neutrophils to
skeletal tissues at ZT13 is dependent on circadian noradrenergic
input to those skeletal tissues, producing rhythmic expression of
the adhesion molecule ICAM-1 (Scheiermann et al., 2012). The
glucocorticoids are under clock control. The SCN and adrenal
clock drive rhythms in glucocorticoid secretion from the adrenal
glands. The SCN controls the release of adrenocorticotropin
(ACTH) from the pituitary gland and ACTH in turn stimulates
release of glucocorticoids from the adrenal gland (Dickmeis
et al., 2013). The adrenal clock then controls sensitivity of the ad-
renal gland to ACTH (Oster et al., 2006). Glucocorticoids exhibit
broad anti-inflammatory properties and can control cytokine pro-
duction and leukocyte trafficking (Coutinho andChapman, 2011).
Glucocorticoids peak as the mice transition to the active phase,
and may possibly be required at that time because of the height-
ened risk of infection and injury. A comprehensive analysis of the
role and targets of glucocorticoids in the circadian control of
innate immunity has yet to be performed. Importantly, lack of
endocrine rhythms does not ablate the rhythms in immune cell
function because mice lacking the adrenal glands and spleno-
cytes in culture still maintain rhythms of cytokine release over a
number of days (Keller et al., 2009). This suggests that the intra-
cellular immune clock also plays a role in determining the circa-
dian rhythm of immune function.
In simple terms, the circadian system may partition the im-
mune system into two states over the circadian day (Figure 2),
one being a state of heightened alert as the animal prepares to
transition to activity and the risk of infection or injury is greatest.
This state would require an increase in leukocyte numbers along
with increased sensitivity of immune cells to infectious agents or
danger signals. The second state would occur when the animal
rests and the risk of infection and injury is lessened. This state
may provide an opportunity for resolution of inflammation and
repair of tissues.
Figure 3. BMAL1 Is the Central Mediator on the Circadian Control of
the Immune System and Promotes an Anti-inflammatory State
BMAL1 directly represses Ccl2 expression, leading to lower numbers of the
Ly6Chi inflammatory monocytes in circulation and lower recruitment of these
inflammatory monocytes into inflamed tissues. BMAL1 sequesters CLOCK
and prevents it from acetylating and activating p65, which leads to lower
amounts of transcriptionally active NF-kB, leading to less induction of spe-
cific genes such as cytokines and regulators of survival and proliferation.
BMAL1 drives the expression of Nr1d1 (encoding REV-ERBa) that can inhibit
Il6 and Ccl2 expression. BMAL1 drives the expression of Rora that can in-
crease the expression of IkB, a major negative regulator of NF-kB. This
would have the effect of retarding the NF-kB complex as a nonactive form in
the cytoplasm, preventing it from translocating into the nucleus and acti-
vating a range of genes including cytokines.
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dian control given that a clock systemwould enable a precise, in-
tegrated, and cohesive response across a number of immune
cells. The molecular clock could act as a ‘‘ground controller’’ for
immune cells, orchestrating a response, dependent on the inte-
gration of a range of inputs, including neural, hormonal, and local
factors along with the circadian phase of gene expression within
the cell. There is a daily rhythm to life, and with that comes daily
challenges for which an organism must prepare for and respond
to. For example, the clock system prepares an organism to antic-
ipate the onset of activity and feeding, but with that comes the
increased threat of infectionassociatedwith foragingand feeding.
Given the intense energy demands for mounting an immune
response, a clockmight allow the body to utilize energy differently
across tissues during periods of rest versus periods of activity. If
the immunesystemneeds tobe ‘‘poised for attack’’ just as the an-
imal enters the activity and feeding phase, a clock might then
allow for the enhancement of immune function, with resolution
and repair of tissues occurring at alternative times (Figure 2).
Specific Clock Proteins in Immune Cell Function
More recently, roles for the specific clock proteins in the immune
response have been studied. Mice with clock gene manipula-
tions have unveiled the important contribution of the core clock
genes on the immune response. In this section we will discuss
the core clock components, paying particular attention to
BMAL1, CLOCK, REV-ERBa, and RORa and the emerging
data surrounding their impact on the immune system.
BMAL1
BMAL1 is the central clock component and is the only single
clock gene knockout in which the mouse loses all rhythmic
behavioral activity (Bunger et al., 2000). Global deletion ofBmal1 causes a range of underlying pathologies under steady-
state conditions related to accelerated aging (Kondratov et al.,
2006), thus making them unsuitable for investigating immune
function. By using a mouse model in which Bmal1 was selec-
tively deleted from myeloid cells, Nguyen et al. (2013) investi-
gated the role of myeloid BMAL1 in the clearance of the
gram-positive bacterium Listeria monocytogenes. Ly6Chi mono-
cytes provide the first line of defense against this bacterium and
the authors had detected a diurnal variation in the absolute
numbers of these specific monocytes in blood and in spleen un-
der basal conditions and enhanced recruitment of these mono-
cytes to an inflamed peritoneum at ZT8 versus ZT0. Improved
bacterial clearance was observed at ZT8 versus ZT0 and this
was likely to be due to the higher recruitment of Ly6Chi
monocytes at sites of infection and a higher production of the
proinflammatory cytokines, IL-1b, IL-6, tumor necrosis factor-a
(TNF-a), and interferon-g (IFN-g) and the chemokine ligand
CCL2. The rhythmic oscillation in the numbers of Ly6Chi mono-
cytes in circulation across 24 hr and enhanced recruitment of
these cells into inflamed tissue was entirely dependent on
BMAL1 in myeloid cells as shown by the fact that the circadian
control over Ly6Chi cell number was abolished in the myeloid
BMAL1-depleted mice. The authors found that BMAL1 binds
to E-boxes in the promoters ofCcl2 (encoding chemokine ligand
2; Ccl2), Ccl8, and S100a8 (encoding S100 calcium binding pro-
tein A8) and recruits with it members of the polycomb repressor
complex (PRC2) epigenetically marking histones for repression.
The authors went on to show that BMAL1 reduces Ccl2 tran-
scription and attenuates Ly6Chi monocyte numbers and inflam-
mation at an inflamed site.
Myeloid deletion ofBmal1 also exacerbatesmetabolic disease
driven by a high-fat diet. The authors speculated that this could
be due to BMAL1 limiting Ly6Chi monocytosis and recruitment
into metabolically stressed tissues such as the fat pads. The
absence of BMAL1 in these cells leads to chronic inflammation,
insulin resistance, and hyperglycemia.
BMAL1 therefore functions as an anti-inflammatory molecule
in monocytes in part because of its repression on Ccl2. This
anti-inflammatory effect of BMAL1 was confirmed previously in
another study (Gibbs et al., 2012). Peritoneal macrophages lack-
ing BMAL1 produced higher amounts of IL-6 in response to LPS
at ZT0 in comparison to wild-type peritoneal macrophages. In
circulating monocytes and in peritoneal macrophages, Bmal1
mRNA is high at ZT0 and low at ZT12 and this could impact
the response to LPS or infection at these two times. However,
it is not the absolute amount of Bmal1 mRNA but the binding
of BMAL1 to gene promoters that will determine the magnitude
of response. ChIP-seq analysis conducted on mouse livers har-
vested every 4 hr across the 24 hr revealed that BMAL1 binding
to gene promoters rises from circadian time (CT, see Box 1) 0 to
CT8 and this then falls from CT12 to CT20 (Koike et al., 2012).
When the animals transition to activity, the reduced binding of
BMAL1 to promoters may allow for a more robust inflammatory
response, with better clearance of a pathogen. However, exces-
sive inflammation leading to sepsis can occur when BMAL1 is
absent in myeloid cells. Nguyen et al. (2013) demonstrated
this: a nonlethal dose of Listeria in wild-type mice caused
massive lethality in mice lacking myeloid BMAL1 when chal-
lenged at both ZT0 and ZT8.Immunity 40, February 20, 2014 ª2014 Elsevier Inc. 181
Box 1. Glossary of Terms Used in Circadian Biology
Circadian time
(CT)
Corresponds to time without the zeitgeber of
light. The lights remain off from CT0 onward.
Diurnal Daily rhythms with the zeitgeber of light.
Period length The time to complete a full cycle.
Zeitgeber An environmental cue that synchronizes the
endogenous rhythm of the clock in an organism
with the Earth’s 24 hr cycle. Examples include
light, food, and temperature.
Zeitgeber time
(ZT)
Corresponds to the time (hours) after onset of
light. In an animal facility with 12 hr of light and
dark, lights go on at ZT0 and off at ZT12.
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by BMAL1? Silver et al. (2012b) observed that the expression of
TLR9, the pattern recognition receptor that recognizes bacterial
and viral DNA, has a circadian pattern of expression. It is
controlled directly by CLOCK:BMAL1, which binds E-boxes in
the TLR9 promoter. TLR9 expression in spleen cells was far
greater in mice at ZT19 versus ZT7. This daily variation in TLR9
led to a more severe response in a model of cecal ligation
puncture when performed at ZT19 versus ZT7. The control of
BMAL1:CLOCK on TLR9 expression has a strong impact on
the adaptive response, as indicated by the fact that immuniza-
tion of mice with CpG as an adjuvant showed maximum respon-
siveness to vaccination at ZT19 versus ZT7, coincident with
enhanced clock controlled expression of TLR9 (Silver et al.,
2012b). This single challenge with CpG at ZT19 resulted in a
more marked response to antigen (OVA) 4 weeks after the initial
immunization. This illustrates that the circadian control of TLR9
has long-term effects in modulating the magnitude of the adap-
tive immune response, suggesting that time of vaccination could
have a significant impact on efficacy. If the phase of TLR9
expression is similar in humans, the optional time to vaccinate
humans may also be during the middle of the night or early
morning.
CLOCK
The BMAL1 binding partner CLOCK has also been shown to
impact immune signals. Unlike transcription of Bmal1, Clock
mRNA does not alter significantly throughout the day in macro-
phages (Keller et al., 2009). However, CLOCK has intrinsic his-
tone acetyl transferase (HAT) activity capable of acetylating
lysine residues on histones and it is this HAT activity of CLOCK
that is essential for circadian gene expression (Doi et al., 2006).
CLOCK can also acetylate the glucocorticoid receptor and this
suppresses binding of the glucocorticoid receptor to its target
genes (Nader et al., 2009). Although not yet investigated, this
may have strong implications regarding the effect of CLOCK
on the immune system.
The daily variations observed in lethality from sepsis correlate
with activation of the NF-kB transcriptional complex and CLOCK
converges directly on this key immune transcription. CLOCK is
found in protein complexes with the NF-kB subunit p65 (RELA)
and overexpression of CLOCK leads to enhanced phosphoryla-
tion and acetylation of p65, leading to enhanced transcriptional
activity of the NF-kB complex (Spengler et al., 2012). BMAL1182 Immunity 40, February 20, 2014 ª2014 Elsevier Inc.attenuates the effect of CLOCK on NF-kB most probably by
sequestering CLOCK. This is likely to be another mechanism
by which BMAL1 limits inflammation. Clock mutant mouse
embryonic fibroblasts (MEFs) (Bellet et al., 2012) and bone-
marrow-derived macrophages (BMDMs) (Bellet et al., 2013) are
less responsive to LPS or TNF-a in terms of NF-kB activation,
and the inflamed intestine ofClockmutantmice showed reduced
expression of many proinflammatory, metabolic, and circadian
genes and reduced the number of genes involved in the immune
response oscillating in a circadian manner, compared to wild-
type mice (Bellet et al., 2013). Given that Salmonella and other
pathogens exploit host defenses to their own advantage (Raffa-
tellu et al., 2009),Clockmutantmice also have reduced coloniza-
tion of Salmonella in the gut (Bellet et al., 2013). However, the
absence of CLOCK may not be beneficial against infection
with more susceptible microorganisms. Therefore, conditional
knockouts of CLOCK in discrete immune compartments will pro-
vide a clearer picture on the function of CLOCK in the immune
system.
The Nuclear Receptors REV-ERBa and RORa
There is also compelling evidence for REV-ERBa (also known as
NR1D1) and RORa affecting immunity.
A synthetic agonist for REV-ERBa limits the release of IL-6
from macrophages (Gibbs et al., 2012). This agonist was also
shown to reduce Cxcl11, Ccl2, Cxcl6, and Il19 mRNA but not
Il8 mRNA. The mechanism behind this pharmacological effect
has not yet been described, but it may be due to the ability of
REV-ERBa to recruit the repressor complex NCoR to selected
proinflammatory genes including Il6. REV-ERBa also has effects
on enhancer-derived RNAs (eRNAs). eRNAs are short RNA
strands produced from an enhancer site and play a role in the
transcription of an adjacent gene. Binding of REV-ERBa proteins
that bring in histone deacetylases repress the production of
these eRNAs and thus lead to the inactivation of the adjacent
gene (Lam et al., 2013). Target genes here include the metallo-
proteinaseMmp9 and the chemokine receptorCx3cr1, providing
another mechanism for the anti-inflammatory effects of REV-
ERBa activation. In a macrophage, BMAL1 induces the tran-
scription of Nr1d1 (Figure 1), thus suggesting that some of the
anti-inflammatory effects of BMAL1 may be through its direct
regulation on REV-ERBa. In support of this, a recent study
showed that REV-ERBa also represses Ccl2 by binding to an
RORE sequence in the promoter of Ccl2 (Sato et al., 2014).
As stated above, BMAL1 represses Ccl2 by binding to an E-
box in the Ccl2 promoter (Nguyen et al., 2013). This indicates
that BMAL1 and REV-ERBa cooperate across the circadian cy-
cle to repress Ccl2 transcription under inflammatory conditions.
The effect of REV-ERBa is possibly cell type specific. REV-ERBa
has been shown to drive Th17 cell differentiation by repression
of Nfil3 transcription (Figure 1, loop 2), which in turn will allow
RORgt to induce IL17 production (Yu et al., 2013). In adaptive im-
munity, REV-ERBa may actually promote inflammation.
BMAL1 also controls the expression of RORa, and mice defi-
cient in RORa (the neurological mutant mouse Staggerer) are
susceptible to LPS lethality (Stapleton et al., 2005). RORa has
been shown to induce the transcription of IkBa (nuclear factor
of kappa light polypeptide gene enhancer in B cells inhibitor,
alpha) and limit NF-kB translocation to the nucleus. Therefore,
Immunity
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tory could be via induction of RORa, which in turn will induce
IkBa and limit NF-kB (Delerive et al., 2001). Therefore, both
nuclear receptors REV-ERBa and RORa, which are components
of the molecular clock, also have strong anti-inflammatory
capability.
PER and CRY
Two other clock proteins, PER and CRY, also modulate inflam-
mation. The PER2 mutant leads to the loss of a daily rhythm in
IFN-g (Arjona and Sarkar, 2006). The oscillation in mortality
from LPS is abolished in PER2-deficient mice, with Per2/
mice being protected against LPS-induced lethality at all time
points analyzed (Liu et al., 2006). The serum concentrations of
IFN-g and IL-1b were lowered dramatically in the Per2/ mice
with LPS injection, but amounts of TNF-a, IL-6, and IL-10 were
normal. The impaired IFN-g was attributed to defective natural
killer (NK) cell function. It was also observed that Per2 mutants
have reduced amounts of Tlr9 mRNA in macrophages and acti-
vation of TLR9 by CpG produced less TNF-a and IL-12 from
these macrophages (Silver et al., 2012b). Therefore, PER2 may
function to upregulate proinflammatory cytokines at certain
stages of the circadian cycle. Per2mRNA rhythms are antiphase
to Bmal1 and Per2 mRNA peaks in macrophages just after
the animals enter the active phase (Keller et al., 2009). PER2
is the negative component of the feedback loop that inhibits
BMAL1:CLOCK activity as the animal enters the active phase
(Figure 1). Therefore, PER2 may promote inflammation in part
by repressing the activity of BMAL1. PER2 abundance also in-
hibits the function of REV-ERBa (Preitner et al., 2002) and repres-
sing REV-ERBa could lead also to greater inflammation from the
mechanisms discussed above (Figure 3). The other components
of the negative feedback loop are the cryptochromes (Figure 1).
Absence of the cryptochrome CRY1 and CRY2 in fibroblasts and
BMDMs leads to increased Il6, Tnfa, Cxcl1, and Inos mRNA at
baseline. Upon LPS stimulation, IL-6 and TNF-a expression are
significantly higher in the BMDMs lackingCry1 andCry2. In fibro-
blasts this was due to CRY1 binding adenylate cyclase and
limiting cAMP production. In the absence of CRY1, elevated
cAMP increases PKA activity, leading to enhanced phosphory-
lation of p65 and NF-kB activation (Narasimamurthy et al.,
2012). Cry1/Cry2/ mice have heightened inflammatory joint
disease and enhanced production of TNF-a in a model of
collagen-induced arthritis (Hashiramoto et al., 2010). Treatment
of these mice with anti-TNF-a antibody reduced the severity of
the disease in the Cry1/Cry2/mice, and ectopic expression
of Cry1 in mouse embryonic fibroblasts from Cry1/Cry2/
mice significantly reduced activation of the TNF-a promoter
luciferase construct. This may again be due to the effects of
Cry1 to limit PKA-induced phosphorylation of p65 and NF-kB
activation in fibroblasts (Narasimamurthy et al., 2012).
Inflammation Disrupts the Molecular Clock
As discussed above, the clock can impact the inflammatory pro-
cess in a number of ways. In a reciprocal fashion, inflammation
induced by agents such as LPS, TNF-a, and IFN-g (Cavadini
et al., 2007; Kwak et al., 2008; Lundkvist et al., 2002; Marpega´n
et al., 2005; Okada et al., 2008) or acute bacterial infection
(Bellet et al., 2013) can affect the circadian clock. The oscilla-tions in the clock genes can be disrupted with inflammation
and infection, with effects on the expression of core clock genes
and clock-controlled genes, including clock-controlled meta-
bolic genes being reported (Bellet et al., 2013). Rodent studies
indicate that LPS transiently suppresses clock gene expression
and oscillation in the SCN (Okada et al., 2008) and phase-shift
locomotor activity (Marpega´n et al., 2005, 2009). One possible
explanation for this is that TNF-a and IL-1b can inhibit the ability
of BMAL1:CLOCK to induce activation of E-box-dependent
genes in the SCN and liver (Cavadini et al., 2007). Also, the
NF-kB subunit RelB interacts directly with BMAL1 to repress
the circadian gene Dbp (Bellet et al., 2012). The mRNA expres-
sion of Bmal1 was repressed in the spleens across the full
circadian day in mice subjected to collagen-induced arthritis
versus controls (Hashiramoto et al., 2010). The constitutively
low expression of BMAL1 in this model of arthritis could promote
further inflammation from immune cells by the mechanisms
stated above (Figure 3). The effect of cytokines on the circadian
system is important given the increased use of biotherapeutics
such as anti-TNF-a for chronic inflammatory conditions such
as arthritis. Anti-TNF-a, by relieving the repression on the
BMAL1:CLOCK heterodimer, may restore the function of the
clock heterodimer and its ability to repress inflammatory genes
(Figure 3). This could be another mechanism of action for this
biological therapy in chronic diseases such as rheumatoid
arthritis (RA).
Molecular Clocks in Human Health and Disease
The recent work identifying the roles for clock proteins such as
BMAL1 and REV-ERBa in immunoregulation may provide new
insights into the pathogenesis of infectious and inflammatory
diseases. It is well known that inflammatory diseases such as
asthma (Barnes et al., 1980; Kraft et al., 1996), RA (Haus et al.,
2012), and atherosclerosis (Paschos and FitzGerald, 2010)
have strong circadian components with exacerbations at night
and into the early morning hours. There is also an intimate link
between circadian rhythms and cancer, a disease associated
with aberrant inflammation (Sahar and Sassone-Corsi, 2009).
In healthy humans, the proinflammatory cytokines TNF-a and
IL-6 peak in serum at 3 am and 6 am, respectively (Cutolo and
Straub, 2008). In RA patients, the peak of both cytokines shift for-
ward to the early morning with peak amounts of IL-6 10-fold
higher in the serum of patients with RA versus controls (Cutolo
and Straub, 2008). In addition, oscillations in clock proteins are
lost in synovial fibroblasts cultured from patients with RA (Kouri
et al., 2013). These data suggest severe circadian disruption in
RA. The irregularity in the amount and timing of these cytokines
might be responsible for the symptoms of stiffness and pain for
RA patients in themorning hours. Therefore, the underlying basis
of many inflammatory conditions could depend on a perturbed
clockwork system both systemically and locally. Chronic disrup-
tion of the external cues of light to the molecular clock, as
imposed by shift work and airline travel, augments the inflamma-
tory response (Castanon-Cervantes et al., 2010) and increases
susceptibility to many metabolic diseases with inflammatory
features, such as atherosclerosis, obesity, and diabetes
(Antunes et al., 2010). Our clock and output rhythms deteriorate
and have a reduced amplitude with advancing age (Froy and
Chapnik, 2007). Dampened circadian rhythms also occur withImmunity 40, February 20, 2014 ª2014 Elsevier Inc. 183
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and coincident metabolic disease. Therefore, the modern 24 hr
society, in terms of our ad hoc pattern of activity, continuous
caloric consumption, and high exposure to ambient light, can
run at odds with our internal clock. It has also been concluded
that ‘‘shift work that involves circadian disruption is probably
carcinogenic to humans’’ (Straif et al., 2007) and can lead to
higher incidence of cardiovascular disease and obesity (Karls-
son et al., 2001; Stevens, 2009). Such studies on shift work
might, however, be confounded by other variables such as
gender, age, and weight. Mice that undergo a model of jet lag
(akin to one transatlantic flight every week for 4 weeks) followed
by recovery for 1 week, however, produce three times as much
IL-6 upon challenge with LPS (Castanon-Cervantes et al.,
2010). Conversely, recovery from sepsis induced in rats by
caecal ligation and puncture is impaired when the regular
12:12 light:dark cycle is replaced by constant conditions (either
constant light or constant darkness) after surgery (Carlson and
Chiu, 2008). These observations highlight the possibility that
recovery of patients from sepsis could be improved by simple
measures such as reducing nocturnal light and noise and
improving quality of sleep in intensive care units (ICUs) (Hrushe-
sky and Wood, 1997; Herdegen, 2002).
Concluding Remarks and Future Directions
The picture that is fast emerging is that time of day is critical in
terms of the type of immune response generated by an organ-
ism. The type of immune response can be broadly partitioned
into two states, one of heightened alert and the other of rest
and repair. The last decade provided a number of descriptive
insights regarding the rhythmic changes that occur in immune
parameters, and this decade has provided some of the molec-
ular mechanisms underpinning these descriptions. What is
intriguing is that the key components of the molecular clock,
whose expression and activity will change across the circadian
day, have direct relationships with important components of
the immune system. We have detailed the data that we
know so far connecting the core clock components, most
notably BMAL1, CLOCK, and REV-ERBa and RORa, with
important regulators of immune function and inflammation.
BMAL1 appears to be a central mediator connecting both
the clock and immune system together, its role being to limit
inflammation.
However, we are only at the beginning of our journey to
understand the tight coupling of the circadian and immune sys-
tems and how disturbances to this relationship can lead to
pathology and disease. There are still a number of questions
to answer, among them: (1) What are the main signals that
entrain or perturb the immune cell clock under different situa-
tions such as infection or inflammation? (2) What role do the
clock proteins play in each type of immune cell? (3) What role
does the clock play in the homeostatic functioning of the
immune system? (4) Is the response of the human immune
clock partitioned in the same way as the mouse immune clock?
(5) Are inflammatory diseases in essence diseases of clock
dysfunction? One question to investigate in this last regard
is whether the anti-inflammatory effects of BMAL1 and REV-
ERBa are somehow disrupted in diseases such as RA, giving
rise to an inflammatory phenotype.184 Immunity 40, February 20, 2014 ª2014 Elsevier Inc.Given that the molecular clock may fundamentally regulate
many if not all aspects of our immune system, an understanding
of how the clock and immune function intersect may reveal
much-needed therapeutic opportunities for some of our most
common chronic diseases. These insights might also provide
rationale for chronotherapy, the dosing of medications with
reference to 24 hr rhythms of disease activity, for existing and
upcoming treatments of immune diseases.ACKNOWLEDGEMENTS
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